Finance

Beta
Lists
TENX:NASDAQ
Tenax Therapeutics Inc
$16.26
+5.17%
(+0.80) 1D
$16.59
+2.03% (+0.33)
After hours
Closed: Jul 6, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TENX...
Open
$15.47
High
$16.61
Low
$15.28
Mkt. cap
431.30M
Avg. vol.
1.11M
Volume
0.00
52-wk high
$18.38
52-wk low
$5.73
EPS
-$1.40
Beta
0.92
Shares outstanding
26.52M
No. of employees
15
Open
$15.47
High
$16.61
Low
$15.28
Mkt. cap
431.30M
Avg. vol.
1.11M
Volume
0.00
52-wk high
$18.38
52-wk low
$5.73
EPS
-$1.40
Beta
0.92
Shares outstanding
26.52M
No. of employees
15
News stories
From sources across the web
About Tenax Therapeutics Inc
CEOChris Giordano
Employees15
Founded1967
Headquarters-
SectorBiotechnology
Websitetenaxthera.com
Analyst ratings
Based on 6 analysts giving stock ratings to TENX in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for TENX in the last 3 months.
Highest
Current $16.26
$50.00 (+207.50%)
Average
$37.40 (+130.01%)
Lowest
$27.00 (+66.05%)
Analyst
Recommendation
Action
Price target
Projected
Date
Gaurav Maini
LifeSci Capital
Buy
Maintained
$35.00
+115.3%
07/06/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Maintained
$35.00
+115.3%
06/24/2026
Seamus Fernandez
Guggenheim
Buy
Maintained
$40.00
+146%
06/22/2026
Unknown Analyst
Chardan Capital
Buy
Initiated
$27.00
+66.1%
06/22/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$50.00
+207.5%
06/12/2026
Matt Phipps
William Blair
Buy
Maintained
-
-
05/12/2026
Unknown Analyst
Roth MKM
Buy
Maintained
$30.00
+84.5%
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.12M
10.33M
10.54M
11.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.67M
6.48M
5.91M
5.03M
Operating expense
11.79M
16.81M
16.45M
16.57M
Total operating expenses
11.79M
16.81M
16.45M
16.57M
Operating income
-11.79M
-16.81M
-16.45M
-16.57M
Other non operating income
-9.00K
-15.00K
-9.00K
-4.00K
EBT including unusual items
-10.85M
-15.80M
-15.54M
-15.72M
EBT excluding unusual items
-10.85M
-15.80M
-15.54M
-15.72M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.85M
-15.80M
-15.54M
-15.72M
Net profit margin
-
-
-
-
Earnings per share
-0.27
-0.40
-0.38
-0.35
Interest and investment income
954.00K
1.02M
918.00K
861.00K
Interest expense
-
-
-
-
Net interest expenses
954.00K
1.02M
918.00K
861.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer